Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction.

Autor: Kalkan BM; Koç University, Graduate School of Health Sciences, Istanbul, Turkey.; Koç University, Research Center for Translational Medicine, Istanbul, Turkey., Ozcan SC; Koç University, Research Center for Translational Medicine, Istanbul, Turkey., Cicek E; Koç University, Graduate School of Health Sciences, Istanbul, Turkey.; Koç University, Research Center for Translational Medicine, Istanbul, Turkey., Gonen M; Koç University, School of Medicine, Istanbul, Turkey.; Koç University, College of Engineering, Department of Industrial Engineering, Istanbul, Turkey., Acilan C; Koç University, Research Center for Translational Medicine, Istanbul, Turkey. cayhan@ku.edu.tr.; Koç University, School of Medicine, Istanbul, Turkey. cayhan@ku.edu.tr.
Jazyk: angličtina
Zdroj: Cell death & disease [Cell Death Dis] 2024 Mar 16; Vol. 15 (3), pp. 222. Date of Electronic Publication: 2024 Mar 16.
DOI: 10.1038/s41419-024-06601-0
Abstrakt: Unlike normal cells, cancer cells frequently exhibit supernumerary centrosomes, leading to formation of multipolar spindles that can trigger cell death. Nevertheless, cancer cells with supernumerary centrosomes escape the deadly consequences of unequal segregation of genomic material by coalescing their centrosomes into two poles. This unique trait of cancer cells presents a promising target for cancer therapy, focusing on selectively attacking cells with supernumerary centrosomes. Nek2A is a kinase involved in mitotic regulation, including the centrosome cycle, where it phosphorylates linker proteins to separate centrosomes. In this study, we investigated if Nek2A also prevents clustering of supernumerary centrosomes, akin to its separation function. Reduction of Nek2A activity, achieved through knockout, silencing, or inhibition, promotes centrosome clustering, whereas its overexpression results in inhibition of clustering. Significantly, prevention of centrosome clustering induces cell death, but only in cancer cells with supernumerary centrosomes, both in vitro and in vivo. Notably, none of the known centrosomal (e.g., CNAP1, Rootletin, Gas2L1) or non-centrosomal (e.g., TRF1, HEC1) Nek2A targets were implicated in this machinery. Additionally, Nek2A operated via a pathway distinct from other proteins involved in centrosome clustering mechanisms, like HSET and NuMA. Through TurboID proximity labeling analysis, we identified novel proteins associated with the centrosome or microtubules, expanding the known interaction partners of Nek2A. KIF2C, in particular, emerged as a novel interactor, confirmed through coimmunoprecipitation and localization analysis. The silencing of KIF2C diminished the impact of Nek2A on centrosome clustering and rescued cell viability. Additionally, elevated Nek2A levels were indicative of better patient outcomes, specifically in those predicted to have excess centrosomes. Therefore, while Nek2A is a proposed target, its use must be specifically adapted to the broader cellular context, especially considering centrosome amplification. Discovering partners such as KIF2C offers fresh insights into cancer biology and new possibilities for targeted treatment.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: